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gical therapy, which may include enlargement of the
aortic root in addition to replacement of the aortic
valve. The therapeutic option of enlargement of the
LVOT with insertion of a mechanical or bioprosthetic
valve remains limited in children. The need for life-long
C omplex left ventricular outflow tract (LVOT)obstruction in children poses a challenge to the car-
diac surgeon. LVOT obstruction is frequently character-
ized by a combination of subvalvular and valvular
stenosis. Both elements of obstruction may require sur-
Objectives: To evaluate the early results and effectiveness of left ventricu-
lar outflow tract enlargement with aortic allograft or pulmonary auto-
graft in children with complex left ventricular outflow tract obstruction.
Method: The records of 30 children who underwent aortic root enlarge-
ment and replacement with either an aortic allograft (22 patients) or
pulmonary autograft (8 patients) between January 1987 and June 1997
were reviewed. The predominant diagnosis was complex left ventricular
outflow tract obstruction (n = 19), associated with aortic incompetence
in 11 children. Before root enlargement, 27 children underwent surgical
valvotomy (14 patients), balloon dilatation (10 patients), or both inter-
ventions (3 patients). Mean age at root enlargement was 5.4 ± 3.5 years
(range, 2 days–16 years). Most of the children (27 patients) underwent a
Konno aortoventriculoplasty. Concomitant septal myectomy was per-
formed in 4 children, mitral valve procedure in 5 children, and endo-
cardial fibroelastosis resection in 1 child. Results: Five children (17%)
died in hospital. Four of these were infants less than 2 months old. All
had acute aortic incompetence as the result of recent intervention neces-
sitating urgent operation. The fifth child, aged 10 years, died of myocar-
dial failure 2 weeks after the operation. During the follow-up period
(mean length, 4.1 ± 2.8 years), sudden death occurred in 1 child 3
months after the operation. Follow-up echocardiograms (obtained for 23
of the surviving 24 children within 3 ± 2.3 years) showed a left ventricu-
lar outflow tract gradient reduced from a mean of 65 to 11 mm Hg (P =
.001); Z value increased from a mean of –0.5 to 4.1 (P < .001), and aor-
tic incompetence was trivial or mild except in 2 children. Conclusion:
Urgent aortic root enlargement in decompensating neonates carries
higher mortality rates. In older children, the early results of root
enlargement and implantation of allograft or autograft are good.
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anticoagulation and the risks of thromboembolism,
hemorrhage, and prosthetic endocarditis are important
drawbacks of mechanical prostheses.1,2 Although anti-
coagulation is not required when a bioprosthetic valve
is inserted, these valves degenerate rapidly in chil-
dren.3,4 Furthermore, substantial pressure gradients
across small prostheses make these alternatives unat-
tractive for young growing children.
The term extended aortic root replacement was
coined by McKowen and associates6 to describe the
insertion of an aortic allograft as a tubular conduit to
enlarged aortic roots. The insertion of a pulmonary
autograft in combination with the Konno technique7,8
has also emerged as an alternative technique for aortic
root enlargement. Patients with these conduits do not
require anticoagulation, and the incidences of throm-
boembolism and endocarditis is low.9,10
The purpose of our study was to evaluate the early
results and effectiveness of LVOT enlargement with
either aortic allograft or pulmonary autograft in chil-
dren with complex LVOT obstruction.
Subjects and method
Patients. Between January 1987 and June 1997, at The
Hospital for Sick Children in Toronto, Canada, 69 children
underwent aortic valve replacement, among which 30 chil-
dren underwent aortic root enlargement with either aortic
allograft or pulmonary autograft for complex LVOT obstruc-
tion. Details of hospital records were analyzed, including
examination, operative reports, preoperative and postopera-
tive investigations, and echocardiographic follow-up. Follow-
up data were obtained by office examination, telephone calls,
or by direct contact with the referring physicians.
All children had LVOT obstruction. Indications for opera-
tion included isolated LVOT obstruction in 19 children and
LVOT obstruction with aortic incompetence in 11 children.
Three of the children had subacute bacterial endocarditis
superimposed on the hemodynamic lesion (stenosis, 1 child;
incompetence, 1 child; mixed, 1 child). Mixed lesions (aortic
incompetence/stenosis) occurred among children with previ-
ous interventions. Age at extended aortic root replacement
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Fig 1. Age distribution of 30 patients who underwent operation for complex LVOT obstruction.
Table I. Preoperative characteristics of 30 children
studied
Characteristic Value
Mean age (y) 5.7 ± 5
Male 23
Female 7
Mean body surface area (m2) 0.68 ± 0.47
Mean weight (kg) 22 ± 21
Previous interventions (n)
Surgical interventions 14
Balloon angioplasties 10
Combined 13
Mean No. per patient 1.4
Associated diagnoses* (n)
Bicuspid aortic valve 10
Supravalvular aortic stenosis 4
Coarctation 4
Endocardial fibroelastosis 2
Double-outlet right ventricle 1
*Seventeen children.
(Fig 1) was 5.4 ± 3.5 years (range, 2 days–16 years); other
characteristics of the children are summarized in Table I.
Previous procedures. Twenty-seven children (90%) had
37 interventions before aortic root enlargement (8 children
had 2 interventions, and 1 child had 3 interventions). One or
more surgical valvotomies were performed in 14 children; 1
or more balloon valvotomies were performed in 10 children,
and a combination of both was performed in 3 children. The
interval from last surgical valvotomy to the enlargement pro-
cedure was a median of 34.6 months (lower and upper quar-
tiles, 7–63 months), compared with a median of 1 day (lower
and upper quartiles, 0–11 months) for balloon valvotomy (P
= .01).
Preoperative assessment. All children underwent preoper-
ative echocardiography to measure aortic anulus size, to assess
the pulmonary valve in cases where a pulmonary autograft was
planned, and to assess gradients across the LVOT. Mean anu-
lus diameter was 12 ± 6.3 mm (range, 4–24 mm); cumulative
peak pressure gradient across the LVOT obstruction was 65 ±
25 mm Hg (40–111 mm Hg); and Z value was –0.5 ± 1.8.
Linear dimensions were indexed to the body surface area to
allow comparison of measurements between patients of vari-
ous sizes. Corresponding Z values were as follows:
Z = (measured value – mean value of normal control)/SD of
normal control
Echocardiographic data for normal children were derived
from data published by Habbal and Somerville.11 Mitral
valve disease was present in 5 children, and endocardial
fibroelastosis was present in 2 children.
Preparation of aortic allografts. Allografts used in this
series were prepared locally at the Hospital for Sick Children.
The donor is screened for infectious diseases. The aortic allo-
graft conduits are harvested under sterile techniques from a
beating donor heart or within few hours of death. Then the
aortic valve is dissected such that the junction with the
innominate, left common carotid artery, and left subclavian
artery remain with the valve. The dissected allograft is placed
in a solution of RPMI 1640 cell culture solution media with
240 m g/mL cefoxitin, 120 m g/mL lincomycin, 150 mg of co-
listimethate (Coly-mycin M), and 50 m g/mL vancomycin at
2°C to 6°C for 24 ± 2 hours to sterilize it. Culture samples are
taken after sterilization. Then the allograft is rinsed in
Ringer’s lactate solution and placed in a solution of cell cul-
ture media with 8% to 12% dimethyl sulfoxide (C2H6OS).
The allograft is then packaged in a double bag. Freezing and
storage is carried out in a controlled-rate freezer (Planer
KRYO10; Planer Products Ltd, Sudbury-on-Thames,
Middlesex, United Kingdom) at a rate of approximately –1°C
per minute. The allografts are stored at –100°C or lower. 
A nonsterile team member does the thawing by placing the
frozen allograft in 2 L of warm sterile saline solution for a
maximum of 15 minutes. Rinsing is done in the sterile field
by adding 1 L of 5% dextrose in lactated Ringer’s solution to
the basin. The allograft is allowed to soak for at least 5 min-
utes before implantation. 
Operative technique. Standard technique for cardiopul-
monary bypass with moderate hypothermia and multidose or
continuous antegrade blood cardioplegia was used. The aorta
was transected well above the valve commissures. The dis-
eased aortic valve was removed, and large coronary buttons
were mobilized. To relieve the subvalvular obstruction in 27
patients, an incision was made in the right ventricular
infundibulum, followed by an incision across the aortic anulus
and extended into the conal septum, as described by Konno
and coworkers.12 Posterior root enlargement was performed in
3 patients, as described by Manougian and Seybold-Epting.13
All aortic allografts (n = 22) implanted had been cryopre-
served. The attached anterior leaflet of the donor mitral valve
was used to patch the septal defect that was created in
enlargement of the subvalvular lesion. 
In children with pulmonary autografts (n = 8), the conduit
was harvested by division of the main pulmonary artery at the
bifurcation; dissection was then carried posteriorly to expose
the right ventricular muscle bar. An incision in the right ven-
tricular outflow tract was made at a reasonable distance from
the pulmonary valve, to allow the defect in the conal septum
to be patched.8 Special care was taken to avoid injury to the
first septal perforator.
Both the allografts and autografts were implanted as “mini-
roots” with continuous or interrupted proximal (surgeon’s
preference) and continuous distal suture lines. Excision of the
native sinus wall with and implantation of the coronary but-
tons completed the LVOT reconstruction. The right ventricu-
lar outflow tract was reconstructed with a pulmonary allograft.
Mean total cardiopulmonary bypass time was 187 ± 58
minutes for allografts, compared with 232 ± 43 minutes for
autografts (P = .02). Myocardial ischemic time was 124 ± 43
minutes for allografts versus 137 ± 42 minutes for autografts
(P = .24).
Additional procedures were performed in 10 children: sep-
tal myectomy (4 patients), mitral valve repair (4 patients),
mitral valve replacement (1 patient), and endocardial fibro-
elastosis resection (1 patient).
Postoperative evaluation. Follow-up in surviving children
is complete in all cases. Mean follow-up was 4.1 ± 2.8 years
(range, 1 month–10 years). Results were assessed by
echocardiography, degree of aortic incompetence, presence
of residual ventricular septal defect, degree of residual LVOT
obstruction, transvalvular gradient, mitral regurgitation, and
annular size. Follow-up echocardiograms were obtained
within 3 ± 2.3 years for 23 of 24 children.
Statistical analysis. Data are expressed as means ± 1 SD.
A 2-tailed, paired Student t test was used to compare contin-
uous variables and Mann-Whitney U statistics for highly
skewed data. Discrete variables were compared with the c 2
test. Risk factors were identified by logistic regression.
Variables tested were age, weight, body surface area, previ-
ous intervention, type of enlargement, annular size, Z value,
conduit used, and myocardial ischemic time. Pearson’s corre-
lation and linear regression was used to determine the relation
between preoperative and postoperative Z values. Kaplan-
Meier curves were used to estimate survival.
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Results
Mortality and morbidity. Five children (17%) died
early after operation, 4 within 24 hours. Four children
were younger than 2 months, were urgently referred for
operation, and had severe aortic incompetence after
failed intervention (balloon angioplasty, 3 children;
surgical valvotomy, 1 child). Two of these children had
implantation of aortic allografts; and two children had
insertion of a pulmonary autograft. The fifth child (10
years old) had low cardiac output syndrome and multi-
organ dysfunction after aortic allograft implantation
and died 2 weeks later. There was no statistical differ-
ence (P = .81) between the proportion of children with
allografts or autografts who died.
During follow-up there was 1 late death; a 5-year-old
child who died 3 months after Konno enlargement of
the aortic root and implantation of an aortic allograft.
An arrhythmia was likely responsible for the out-of-
hospital sudden death.
One reoperation for pulmonary artery stenosis was
needed in a child who had had a pulmonary auto-
graft.
Five-year survival is 78% (95% confidence interval,
0.71-0.85; Fig 2). The longest follow-up was 10years
in a child who underwent a Konno procedure with a 20-
mm aortic allograft implanted at age 6 years. He
remains asymptomatic, with a gradient of 13 mm Hg
across the LVOT and no aortic incompetence.
Univariate risk factor analysis revealed lower operative
age (estimate,–0.24; SE, 0.12; P = .02) and weight
(estimate,–0.28; SE, 0.11; P = .01), smaller body sur-
face area (estimate,–0.20; SE, 0.07; P = .01) and anu-
lus size (estimate,–0.30; SE, 0.13; P = .01), and
urgency of operation (estimate, 1.005; SE, 0.31; P <
.01) to be predictors of death. Multivariate analysis
revealed urgent operation (estimate, 0.735; SE, 0.319;
P = .01) and young age at operation (estimate, –0.58;
SE, 0.24; P = .02) to predict death.
Echocardiographic studies. Echocardiographic fol-
low-up revealed no ventricular septal defect or mitral
regurgitation. Aortic incompetence was graded as
absent in 14 patients, mild in 7 patients, and moderate
in 2 patients. Preoperative to postoperative changes in
mean pressure gradient, annular size, and Z value of the
aortic anulus were all statistically significant (Table II).
Five of the 7 children with mild aortic incompetence
in follow-up had aortic allograft implantation.
Echocardiography immediately after operation showed
no aortic regurgitation in 3 children and mild in 2 chil-
dren. The other 2 children with mild aortic incompe-
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Fig 2. Survival of children after aortic root enlargement (by Kaplan-Meier analysis).
Table II. Comparison of mean variables before and
after operation
Variables Before After P value
Gradient* (mm Hg) 65 ± 25 11 ± 10 .001
Annular size (mm) 12 ± 6.3 17 ± 10.6 .02
Z value –0.5 ± 1.8 4.1 ± 2.2 <.001
*Pressure gradient across left ventricular outflow tract.
tence had pulmonary autograft implantation; both had
no aortic incompetence early after operation.
The 2 children with moderate aortic incompetence had
undergone a Konno enlargement procedure and implan-
tation of an aortic allograft in combination with septal
myectomy, at the ages of 3 months and 2.8 years, respec-
tively. Echocardiography immediately after the opera-
tion showed mild aortic incompetence, which worsened
later. The most recent echocardiographic follow-up was
1.5 years and 5.5 years, respectively; latest clinical fol-
low-up was 3 and 7 years. Both are clinically well.
In this cohort, children undergoing allograft or auto-
graft implantation were of similar age and size of anu-
lus before and after operation, although the autograft
group had a lower Z value after operation (Table III). In
addition, there was a higher correlation between preop-
erative and postoperative Z values in the autograft
group (r = 0.88) than in the allograft group (r = 0.45;
Fig 3). 
Discussion
Management of complex LVOT obstruction in chil-
dren remains difficult. The complex is essentially 2
lesions: a “tunnel-like” subvalvular component and
valvular stenosis (with associated hypoplasia of the
aortic anulus). Their severity determines the choice and
outcome of any surgical repair. Localized myectomy
with or without patch enlargement of the interventricu-
lar septum,14,15 with preservation of the aortic valve is
possible in those cases where the aortic valve and aor-
tic anulus are morphologically normal. The presence of
valvular and subvalvular obstructions requires simulta-
neous repair of both lesions. Enlargement of the aortic
and subaortic regions with an incision in the conal sep-
tum is the only acceptable technique in small children
with tunnel-like obstruction of the left ventricle. In
older children, posterior enlargement through an inci-
sion in the subaortic curtain (with or without incising
the mitral valve) is an acceptable alternative.
The incidence of aortic root enlargement in children
is relatively higher compared with adults. This is main-
ly due to the fact that the indication of aortic valve
replacement in children is mainly congenital and com-
monly is associated with some form of hypoplasia of
the anulus or the LVOT. The question remains as to the
best choice of valve replacement in children. Some of
the issues considered in children are durability, size
availability, anticoagulation requirements, and growth
potential. The durability of bioprosthetic valves is lim-
ited in children because of rapid calcification leading to
clinically significant stenosis.4 Mechanical prostheses
require lifelong anticoagulation and carry a risk of
thromboembolism and hemorrhage.2 Moreover, neither
of these prostheses is of a size suitable for implantation
in a neonate.
Aortic allografts are available in a variety of sizes
and do not require anticoagulation. However, degener-
ation remains a concern, as does the lack of growth
potential. Previous reports by Clarke and col-
leagues16,17 have indicated accelerated degeneration of
allografts in 11 surviving children under the age of 3
years, which has led them and others18 to administer
cyclosporine (INN: ciclosporin) to some children to
prolong allograft life, on the presumption that the
degeneration is immunogenically mediated. Eight of
the children who underwent operation in our series
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Fig 3. Scattergram and linear regression for the relationship
between preoperative and postoperative Z values in both
groups.
Table III. Comparison of patients with allograft and
autograft
Variable Allograft Autograft P value
Patients (n) 22 8 —
Age at operation (y) 5.5 ± 4.6 4.9 ± 6.1 .32
Weight (kg) 21 ± 18 25 ± 22 .5
Anulus (mm)
Before operation 12 ± 4.6 15 ± 10 .60
After operation 19 ± 3.9 18 ± 11.3 .10
Z values
Before operation –0.5 ± 2.0 –0.6 ± 1.0 .60
After operation 4.4 ± 2.3 2.3 ± 0.5 .10
Cardiopulmonary 187 ± 58 232 ± 43 .02
bypass time (min)
Ischemic time (min) 124 ± 43 137 ± 42 .24
Data are means.
were under 3 years of age. Our mean follow-up was 3
years, slightly longer than Clarke’s follow-up of 2.3
years. None of the children in our series has required
explantation of the allograft. Gerosa and colleagues19
also reported good results of allografts implanted in
children; compared with those children having pul-
monary autografts, the children in their report faired
well in terms of death and freedom from reoperation,
endocarditis, and complications. There was slightly
faster valve degeneration in the allograft group,
although the follow-up period in the allograft group
was almost 3 times as long making the comparison
inconclusive.
Pulmonary autografts are usually of appropriate size,
do not require anticoagulation, and are resistant to
immunologically mediated degeneration and to endo-
carditis. The great advantage of pulmonary autografts
over allografts is their growth potential in small chil-
dren.20,21 Insertion of a pulmonary autograft is techni-
cally demanding, requiring expertise in harvesting and
implantation of the conduit; it also converts a single-
valve disease into potentially a double-valve disease. In
our series, there was no significant difference in
myocardial ischemic time between allografts and auto-
grafts; however, total cardiopulmonary bypass time
was longer in the autograft group because of the time
required to reconstruct the right ventricular outflow
tract. This has not translated into a difference in early
mortality rates; nevertheless, one child required reoper-
ation for right ventricular outflow tract obstruction in
the autograft group. Others22 have also reported low
mortality and morbidity rates in reoperations after pul-
monary autograft implantation. Two of the children
with pulmonary autograft implantation progressed
from no to mild aortic incompetence in the follow-up
period. The ramification of this change is still to be
seen with longer follow-up. Dilatation in the pul-
monary autograft could be a concern in the long run. 
The indication for operation is usually the presence
of significant gradient, which in this complex is at more
than one level and for this reason an evaluation of the
entire LVOT should be done before the operation.
Although preoperative Z values were similar between
the autograft and allograft groups, the mean postopera-
tive Z value was greater for the allograft group, likely
because the surgeon selected a larger conduit to accom-
modate growth of the child, whereas autograft size at
the time of implantation remains entirely dependent on
the child’s anatomy. The ability to insert a larger con-
duit is advantageous in neonates; nevertheless, the
growth potential of pulmonary autografts certainly
makes them appealing to the surgeon. When compared
with allografts, the growth potential of pulmonary
autografts may avoid the necessity for further opera-
tions in the LVOT at a later date when allograft
becomes restrictive. There is some evidence that sug-
gests rapid degeneration of allografts in the pulmonary
position for children less than 2 years old.23 Although
this may be an indication for operation in children with
pulmonary autograft implantation, it is a reasonable
trade off to accept reoperating on the right ventricular
outflow tract, which is relatively straightforward rather
than reoperating multiple times on the LVOT. 
The analysis revealed that young age and urgent
operation contributed to a worse outcome. These 2 fac-
tors are highly correlated among our children because
of the fact that 4 young children had catheter interven-
tions followed by urgent operation. The effect of each
factor on outcome is difficult to separate. However, the
indication for operation was urgent and may have con-
tributed to a worse outcome more than the presence of
young age, per se. These results identify these high-risk
decompensating children, and careful consideration of
these children should be done before intervention. 
In our series, one child underwent resection of endo-
cardial fibroelastosis. Children with this pathologic
condition may have small left ventricles. Biventricular
repair is possible in almost all children, regardless of
the size of the LVOT, as long as there remains a near-
”normal” preservation of the left atrioventricular valve
and left ventricle.24
Echocardiographic follow-up revealed good results
overall. Only 2 children progressed to moderate aortic
incompetence, and both children have remained mini-
mally symptomatic. These echocardiographic follow-
up results are short to midterm, and longer follow-up is
required to draw solid conclusions on the fate of each
of the conduits in the setting of aortic root enlargement. 
In conclusion, our series confirms the effectiveness
of relieving LVOT obstruction with the use of extend-
ed aortic root replacement with either aortic allografts
or pulmonary autografts, showing continued relief of
the obstruction during the intermediate follow-up peri-
od. Urgent operation in neonates after a failed valvoto-
my was associated with a high mortality rate. Results
for balloon dilatation of critical stenosis have improved
in recent years; it remains our initial treatment of
choice in neonates with critical aortic stenosis.
Continued follow-up of children undergoing allograft
implantation at a young age is critical so that late per-
formance of these conduits can be documented.
This article was prepared with the assistance of Editorial
Services, The Hospital for Sick Children, Toronto, Ontario,
Canada.
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